| HOME >> BIOLOGY >> TECHNOLOGY |
-Latest in Series of Global Distribution Agreements to Make ZyGEM's Lower-Cost, Rapid and Easy-to-Use DNA Extraction Kits Available to Researchers Everywhere-
-ZyGEM Also Announces Issuance of U.S. Patent for its DNA Extraction Technology-
SOLANA BEACH, Calif. and HAMILTON, New Zealand and ANN ARBOR, Mich., May 28 /PRNewswire/ -- ZyGEM Corp. Ltd. today announced that it has entered into an agreement with Rubicon Genomics, Inc. to incorporate ZyGEM's advanced enzymatic nucleic acid extraction technology into Rubicon's pre-analytical platform products designed to significantly improve the performance of DNA and RNA analytical instruments. The agreement, which will initially focus on diagnostic single-cell whole genome amplification kits, has the potential to be expanded to include products for broader research and diagnostic applications.
ZyGEM's technology uses a proprietary thermophilic enzyme to extract DNA from samples using a single closed-tube system. ZyGEM's approach significantly reduces the time and cost of DNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination, ensuring sample integrity and facilitating extractions from trace samples. It is easily adaptable for use with virtually all off-the-shelf laboratory automation systems. The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification. ZyGEM's technology has been validated for use in highly regulated applications including forensic analysis.
"ZyGEM's unique temperature-controlled DNA extraction technology provides important advantages for the analysis of DNA and RNA, and we are delighted to partner with Rubicon in our drive to make our technology widely available for diverse research and clinical applications," said Paul Kinnon, CEO of ZyGEM. "This new agreement for private-label DNA extractio
'/>"/>
| SOURCE ZyGEM Corp. Ltd. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
2. ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon
3. ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
4. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
5. ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe
6. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
7. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
8. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
9. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
10. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
11. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |